应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INAB IN8bio, Inc.
盘后交易 05-16 18:51:42 EDT
1.02
-0.11
-9.73%
盘后
1.03
+0.01
+0.98%
18:51 EDT
最高
1.15
最低
1.00
成交量
18.64万
今开
1.12
昨收
1.13
日振幅
13.27%
总市值
4,490万
流通市值
2,495万
总股本
4,402万
成交额
19.55万
换手率
0.76%
流通股本
2,446万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
HC Wainwright & Co.:维持IN8bio(INAB.US)评级,由买入调整至买入评级, 目标价由14.00美元调整至12.50美元。
智通财经 · 05-13
HC Wainwright & Co.:维持IN8bio(INAB.US)评级,由买入调整至买入评级, 目标价由14.00美元调整至12.50美元。
In8Bio, Inc.盘中异动 股价大跌5.58%
自选股智能写手 · 04-29
In8Bio, Inc.盘中异动 股价大跌5.58%
In8Bio, Inc.盘中异动 早盘急速下挫5.99%
自选股智能写手 · 04-23
In8Bio, Inc.盘中异动 早盘急速下挫5.99%
In8Bio, Inc.盘中异动 股价大跌5.71%
自选股智能写手 · 04-20
In8Bio, Inc.盘中异动 股价大跌5.71%
In8Bio, Inc.盘中异动 快速下跌5.26%报1.05美元
自选股智能写手 · 04-15
In8Bio, Inc.盘中异动 快速下跌5.26%报1.05美元
In8Bio, Inc.盘中异动 早盘快速跳水5.08%
自选股智能写手 · 04-12
In8Bio, Inc.盘中异动 早盘快速跳水5.08%
In8Bio, Inc.盘中异动 股价大跌5.36%
自选股智能写手 · 04-06
In8Bio, Inc.盘中异动 股价大跌5.36%
In8Bio, Inc.盘中异动 快速拉升5.77%报1.10美元
自选股智能写手 · 04-05
In8Bio, Inc.盘中异动 快速拉升5.77%报1.10美元
In8Bio, Inc.盘中异动 下午盘股价大跌6.36%报1.03美元
自选股智能写手 · 04-04
In8Bio, Inc.盘中异动 下午盘股价大跌6.36%报1.03美元
In8Bio, Inc.盘中异动 下午盘股价大跌7.20%
自选股智能写手 · 03-23
In8Bio, Inc.盘中异动 下午盘股价大跌7.20%
In8Bio, Inc.盘中异动 早盘股价大涨8.33%报1.30美元
自选股智能写手 · 03-20
In8Bio, Inc.盘中异动 早盘股价大涨8.33%报1.30美元
In8Bio, Inc.盘中异动 早盘股价大涨5.26%
自选股智能写手 · 03-18
In8Bio, Inc.盘中异动 早盘股价大涨5.26%
In8Bio, Inc.盘中异动 早盘快速下跌7.19%报1.16美元
自选股智能写手 · 03-14
In8Bio, Inc.盘中异动 早盘快速下跌7.19%报1.16美元
In8Bio, Inc.盘中异动 快速上涨5.50%
自选股智能写手 · 03-13
In8Bio, Inc.盘中异动 快速上涨5.50%
加载更多
公司概况
公司名称:
IN8bio, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日,该公司在一项交易中重新并入美国,在该交易中,该公司转变为一家新成立的特拉华州公司,该公司是一家临床阶段生物技术公司,专注于通过使用同种异体、自体和基因修饰的γ-δT细胞。γ-δT细胞是人体免疫系统中自然产生的细胞,它识别并杀死癌细胞,同时具有保护健康组织的肿瘤识别机制。
发行价格:
--
{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.02,"timestamp":1715889600000,"preClose":1.13,"halted":0,"volume":186426,"hourTrading":{"tag":"盘后","latestPrice":1.03,"preClose":1.02,"latestTime":"18:51 EDT","volume":588,"amount":615.3199500000001,"timestamp":1715899863812},"delay":0,"floatShares":24456386,"shares":44019836,"eps":-0.905548,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.11,"latestTime":"05-16 18:51:42 EDT","open":1.12,"high":1.15,"low":1,"amount":195533.73037439998,"amplitude":0.132743,"askPrice":1.1,"askSize":33,"bidPrice":1,"bidSize":1250,"shortable":0,"etf":0,"ttmEps":-0.905548,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715904000000},"adr":0,"listingDate":1605157200000,"adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.14,"preClose":1.12,"latestTime":"08:35 EDT","volume":121,"amount":137.8600069,"timestamp":1715862927945},"postHourTrading":{"tag":"盘后","latestPrice":1.03,"preClose":1.02,"latestTime":"18:51 EDT","volume":588,"amount":615.3199500000001,"timestamp":1715899863812},"volumeRatio":0.804358},"requestUrl":"/m/hq/s/INAB","defaultTab":"news","newsList":[{"id":"2435034758","title":"HC Wainwright & Co.:维持IN8bio(INAB.US)评级,由买入调整至买入评级, 目标价由14.00美元调整至12.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435034758","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435034758?lang=zh_cn&edition=full","pubTime":"2024-05-13 17:45","pubTimestamp":1715593528,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持IN8bio(INAB.US)评级,由买入调整至买入评级, 目标价由14.00美元调整至12.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131745298b00e754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131745298b00e754&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431951598","title":"In8Bio, Inc.盘中异动 股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431951598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431951598?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:13","pubTimestamp":1714403598,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时13分,In8Bio, Inc.股票出现异动,股价大幅下挫5.58%。In8Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.86%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药,采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429231318861ea21b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429231318861ea21b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429119898","title":"In8Bio, Inc.盘中异动 早盘急速下挫5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119898","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429119898?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:02","pubTimestamp":1713884577,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时02分,In8Bio, Inc.股票出现波动,股价急速下挫5.99%。In8Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232302577922b4b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232302577922b4b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428585660","title":"In8Bio, Inc.盘中异动 股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428585660","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428585660?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:15","pubTimestamp":1713550536,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时15分,In8Bio, Inc.股票出现异动,股价大幅下跌5.71%。截至发稿,该股报0.990美元/股,成交量15.6554万股,换手率0.36%,振幅6.67%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200215367921ec45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200215367921ec45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427009050","title":"In8Bio, Inc.盘中异动 快速下跌5.26%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427009050","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427009050?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:52","pubTimestamp":1713189135,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时52分,In8Bio, Inc.股票出现波动,股价大幅下跌5.26%。截至发稿,该股报1.05美元/股,成交量3.4681万股,换手率0.08%,振幅1.80%。In8Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。其相关个股中,安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大,Longeveron Inc.、Allarity Therapeutics, Inc.、Soligenix, Inc.较为活跃,换手率分别为796.40%、695.07%、690.87%,振幅较大的相关个股有Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Longeveron Inc.,振幅分别为79.05%、75.77%、74.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152152167920a117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152152167920a117&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426273898","title":"In8Bio, Inc.盘中异动 早盘快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426273898","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426273898?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:52","pubTimestamp":1712929928,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时52分,In8Bio, Inc.股票出现异动,股价快速下挫5.08%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。其相关个股中,Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为2280.84%、797.94%、36.59%,振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Qualigen Therapeutics, Inc.,振幅分别为69.81%、60.95%、17.87%。消息层面,截至21时52分,《HC Wainwright & Co.:重申IN8bio评级,由买入调整至买入评级, 目标价14.00美元。》资讯为影响In8Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412215208861e54e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412215208861e54e6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425599410","title":"In8Bio, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425599410","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425599410?lang=zh_cn&edition=full","pubTime":"2024-04-06 01:19","pubTimestamp":1712337590,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日01时19分,In8Bio, Inc.股票出现波动,股价急速下挫5.36%。截至发稿,该股报1.06美元/股,成交量10.1179万股,换手率0.23%,振幅6.72%。In8Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.26%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406011950861e393c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406011950861e393c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425340383","title":"In8Bio, Inc.盘中异动 快速拉升5.77%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425340383","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425340383?lang=zh_cn&edition=full","pubTime":"2024-04-05 03:50","pubTimestamp":1712260247,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日03时50分,In8Bio, Inc.股票出现波动,股价快速上涨5.77%。截至发稿,该股报1.10美元/股,成交量7.8513万股,换手率0.18%,振幅5.58%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为1.54%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040503504787e7e142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040503504787e7e142&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424875632","title":"In8Bio, Inc.盘中异动 下午盘股价大跌6.36%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424875632","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424875632?lang=zh_cn&edition=full","pubTime":"2024-04-04 02:42","pubTimestamp":1712169768,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日02时42分,In8Bio, Inc.股票出现波动,股价急速下挫6.36%。截至发稿,该股报1.03美元/股,成交量11.152万股,换手率0.26%,振幅7.90%。In8Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,方舟生物医药、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Kintara Therapeutics, Inc.涨幅较大,Kintara Therapeutics, Inc.、方舟生物医药、Eiger Biopharmaceuticals, Inc.较为活跃,换手率分别为550.28%、522.52%、173.71%,振幅较大的相关个股有Eiger Biopharmaceuticals, Inc.、Kintara Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ,振幅分别为107.69%、97.51%、78.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040402424887e7dfdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040402424887e7dfdb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421840417","title":"In8Bio, Inc.盘中异动 下午盘股价大跌7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421840417","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421840417?lang=zh_cn&edition=full","pubTime":"2024-03-23 01:42","pubTimestamp":1711129375,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日01时42分,In8Bio, Inc.股票出现异动,股价大幅下跌7.20%。截至发稿,该股报1.16美元/股,成交量8.0694万股,换手率0.19%,振幅7.20%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403230142557a4e8e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403230142557a4e8e8e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420723320","title":"In8Bio, Inc.盘中异动 早盘股价大涨8.33%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420723320","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420723320?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:50","pubTimestamp":1710942655,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时50分,In8Bio, Inc.股票出现异动,股价快速拉升8.33%。截至发稿,该股报1.30美元/股,成交量2742股,换手率0.01%,振幅0.00%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为1.04%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320215056791bbf33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320215056791bbf33&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420474187","title":"In8Bio, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420474187","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420474187?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:32","pubTimestamp":1710768766,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时32分,In8Bio, Inc.股票出现波动,股价大幅上涨5.26%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821324687935648&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821324687935648&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419298992","title":"In8Bio, Inc.盘中异动 早盘快速下跌7.19%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419298992","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419298992?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:27","pubTimestamp":1710430055,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时27分,In8Bio, Inc.股票出现异动,股价急速下跌7.19%。截至发稿,该股报1.16美元/股,成交量5.5496万股,换手率0.13%,振幅7.20%。In8Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.64%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314232735791a812e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314232735791a812e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419684437","title":"In8Bio, Inc.盘中异动 快速上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419684437","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419684437?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:31","pubTimestamp":1710336716,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时31分,In8Bio, Inc.股票出现异动,股价急速上涨5.50%。In8Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。In8Bio, Inc.公司简介:IN8bio Inc 是一家临床阶段的生物制药公司,专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞,发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031321315687e788b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031321315687e788b8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":0.1188},{"period":"1month","weight":0.1078},{"period":"3month","weight":0.0273},{"period":"6month","weight":0.2418},{"period":"1year","weight":-0.5768},{"period":"ytd","weight":-0.1812}],"compareEarnings":[{"period":"1week","weight":0.0243},{"period":"1month","weight":0.0502},{"period":"3month","weight":0.0553},{"period":"6month","weight":0.1752},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.1146}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日,该公司在一项交易中重新并入美国,在该交易中,该公司转变为一家新成立的特拉华州公司,该公司是一家临床阶段生物技术公司,专注于通过使用同种异体、自体和基因修饰的γ-δT细胞。γ-δT细胞是人体免疫系统中自然产生的细胞,它识别并杀死癌细胞,同时具有保护健康组织的肿瘤识别机制。","exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}